Fluvoxamine or placebo in the treatment of panic disorder and relationship to blood concentrations of fluvoxamine

Pharmacopsychiatry

Volumn 31, Issue 4, 1998, Pages 117-121

  Sandmann, J ^a   Lorch B ^a   Bandelow, B ^b   Hartter S ^a   Winter, P ^a   Hiemke, C ^a   Benkert, O ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE; PLACEBO;

ABDOMINAL PAIN; ADULT; AGORAPHOBIA; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; NAUSEA; NERVOUSNESS; ORAL DRUG ADMINISTRATION; PANIC; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE;

EID: 0031710516     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979311     Document Type: Article

References (30)

1. Ballenger, J. C., G. D. Burrows, R. L. DuPont, I. M. Lesesr, R. Noyes, J. C. Pecknold, A. Rifkin, R. P. Swinson: Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. Arch. Gen. Psychiatry 45 (1988) 413-422
2. Black, D. W., R. Wesner, W. Bowers, J. Gabel: A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch. Gen. Psychiatry 50 (1993) 44-50
3. Coryell, W., R. Noyes: Placebo response in panic disorder. Amer. J. Psychiatry 145 (1988) 1138-1140
4. de Beurs, E., A. J. L. M. van Balkom, A. Lange, P. Koele, R. van Dyck: Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone. Amer. J. Psychiatry 162 (1995) 683-691
5. Den Boer, J. A., H. G. M. Westenberg, W. D. J. Kamerbeek, W. M. A. Verhoeven, R. S. Kahn: Effect of serotonin uptake inhibitors in anxiety disorders: a double-blind comparison of clomipramine and fluvoxamine. Int. Clin. Psychopharmacol. 2 (1987) 21-32
6. Den Boer, J. A., H. G. M. Westenberg: Effect of serotonin and noradrenaline uptake inhibitor in panic disorder: a double-blind placebo controlled study with fluvoxamine and maprotiline. Int. Clin. Psychopharmacol. 3 (1988) 59-74
7. Den Boer, J. A., H. G. M. Westenberg: Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology 102 (1990) 85-94
8. Endicott, J., R. L. Spitzer, J. L. Fleiss, J. Cohen: The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbances. Arch. Gen. Psychiatry 33 (1976) 766-771
9. Evans, L., J. Kenardy, P. Schneider, H. Hoey: Effect of selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo. Acta Psychiatr. Scand. 73 (1986) 49-53
10. Gentil, V., F. Lotufo-Neto, L. Andrade, T. Cordas, M. Bernik, R. Ramos, L. Maciel, E. Miyakawa, C. Gorenstein: Clomipramine, a better reference drug for panic/agoraphobia. I. Effectiveness comparison with imipramine. J. Psychopharmacol 7 (1993) 316-324
11. Guy, W. (ed.): ECDEU Assessment Manual for Psychopharmacology, revised. US Department of Health, Education and Welfare, Rockville, Maryland (1976) 217-222
12. Härtter, S., H. Wetzel, E. Hammes, M. Torkzadeh, C. Hiemke: Serum concentrations of fluvoxamine and clinical effects. A prospective open clinical trial. Submitted to Pharmacopsychiatry 1997
13. Härtter, S., H. Wetzel, C. Hiemke: Automated determination of fluvoxamine in plasma by column switching high-performance liquid chromatography. Clinical Chemistry 38 (1992) 2082-2086
14. Hoehn-Saric, R., D. R. McLeod, P. A. Hipsley: Effect of fluvoxamine on panic disorder.J. Clin. Psychopharmacol. 13 (1993) 321-326
15. Hoehn-Saric, R., J. Fawcett, D. J. Munjack, P. P. Roy-Byrne: A multicentre, double-blind, placebo-controlled study of fluvoxamine in the treatment of panic disorder. Poster on the 19th Congress of the Collegium Internationale Neuro-Psychopharmacologicum, Washington DC, June 1994
16. Johnston, D. G., I. E. Troyer, S. F. Whitsett: Clomipramine treatment of agoraphobic women. An eight-week controlled trial. Arch. Gen. Psychiatry 45 (1988) 453-459
17. Kelly, D., W. Guirgis, E. Frommer, N. Mitchell-Heggs, W. Sargant: Treatment of phobic states with antidepressants. Amer. J. Psychiatry 116 (1970) 387-398
18. Klein, D. F.: Delineation of two drug-responsive anxiety syndromes. Psychopharmacology 5 (1964) 397-408
19. Lörch, B., M. Graf-Morgenstern, M. Hautzinger, S. Schlegel, C. Hain, J. Sandmann, O. Benkert: Pharmacological treatment of psychotherapy of panic disorder with agoraphobia: a randomised, placebo-controlled trial of moclobemide, cognitive behaviour therapy, and their combination. Submitted to British Journal of Psychiatry 1997
20. Mavissakalian, M.: The placebo effect in agoraphobia II. J. Nerv. Ment. Dis. 176 (1988) 446-448
21. Megen, H. J. G. M., H. G. M. Westenberg, J. A. den Boer, B. Slaap, A. Scheepmakers: Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks. Psychopharmacology 129 (1997) 357-364
22. Pohl, R., R. Balon, V. K. Yeragani, S. Gershon: Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone. Psychopathol. 22 (Suppl.) (1989) 60-67
23. Rosenberg, N. K., M. Mellergard, R. Rosenberg, P. Bech, J.-O. Ottosson: Characteristics of panic disorder patients responding to placebo. Acta Psychiatr. Scnad. (Suppl.) 365 (1991) 33-38
24. Schweizer, E., W. Patterson, K. Rickels, M. Rosenthal: Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder. Amer. J. Psychiatry 150 (1993) 1210-1215
25. Sheehan, D. V., J. Ballenger, G. Jacobsen: Treatment of endogenous anxiety with phobic, hysterical, and hypochondrical symptoms. Arch. Gen. Psychiatry 37 (1980) 51-59
26. Simpson, R. J., D. M. Sharp, R. L. Holland, G. Kok, J. A. Anstee: A double-blind, placebo-controlled comparison of fluvoxamine, with or without behaviour therapy, in panic disorder. Poster on the VIIth Congress of the European College of Neuropsychopharmacology (ENP), Jersualem, October 1994
27. Smith, R. P., S. J. Baugh, A. D. Clayden, A. Husain, M. A. Supple: The clinical anxiety scale: an instrument derived from the Hamilton Anxiety Scale. Brit. J. Psychiatry 141 (1982) 518-523
28. Spitzer, R., J. B. Williams, M. Gibbon: Structured clinical interview of DSM-III-R (SCID I and II). Biometrics Research Department, New York Psychiatric Institute (1987)
29. Wittchen, H.-U., M. Zaudig, E. Schramm, P. Spengler, W. Mombour, J. Klug, R. Horn: Strukturiertes Klinisches Interview für DSM-III-R. Eine deutschsprachige, erweiterte Bearbeitung der amerikanischen Originalversion des SCID von R. L. Spitzer, J. B. W. Williams, M. Gibbon. Beltz, Weinheim (1990)
30. Woods, S., D. Black, S. Brown, S. Asnis, S. Potkin: Fluvoxamine in the treatment of panic disorder in outpatients: a double-blind, placebo-controlled study. Poster on the 19th Congress of the Collegium Internationale Neuropsychopharmacologicum, Washington DC, June 1994